FDA Withdraws Approval of 54 Abbreviated New Drug Applications from Teva Pharmaceuticals Subsidiaries

Summary

The FDA has withdrawn approval of 54 abbreviated new drug applications from Watson Laboratories, Inc. and Barr Laboratories, Inc., subsidiaries of Teva Pharmaceuticals USA, Inc., following notification from the applicants that the drug products are no longer commercially available.